IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

271.68 6.80 +2.57%
Market cap
$43.7B
P/E
32.6×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a

IQVIA Holdings Inc. 10-K filed Feb 13, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed · accepted 7:39 AM ET · Document on sec.gov · Filing index

What changed

Item 7, Management’s Discussion and Analysis: no comparison — no earlier filing on file